Vaccines May Be Fueling the Increasing Rate of Non-Hodgkin’s Lymphoma Cancer

A recent study holds information showing that vaccines may be fueling the massive increase in non-Hodgkin’s lymphoma, a cancer that directly attacks a primary part of the immune system.

by Heidi Stevenson

The United States rate of non-Hodgkin’s lymphoma nearly doubled between 1975 and 2007, a time when vaccinations have been massively increased. There’s little interest in finding the cause, with lip service paid to pollution and other things presumably outside the control of medicine.

However, a new study, which just crossed my desk, appears to point the finger at vaccines—though that wasn’t, of course, the intent of the researchers. They were simply looking for the best timing for PET/CT scans after H1/N1 (swine  flu) vaccinations. Though they don’t say so, they may have come up with a smoking gun for a connection between vaccines and non-Hodgkin’s lymphoma.

Vaccines Interfere with PET Scans

The study, “Incidence and Intensity of F-18 FDG Uptake After Vaccination With H1N1 Vaccine“, published this month in the journal Clinical Nuclear Medicine, questioned how long flu vaccines interfere with the results of positron emission tomography/computed tomography (PET/CT) in cancer patients.

A type of FDG (fluorodeoxyglucose) is used in PET scans to diagnose and to find cancers. The combination of fluorine (fluorodeoxyglucose) and glucose (fluorodeoxyglucose) allows the scanner to see where glucose metabolism is high, which is where cancer tends to be. However, inflammatory and infectious lesions tend to cause FDG to collect in those same locations, resulting in false positives for cancer on scans.

The researchers examined the scans of patients who had recently received GlaxoSmithKline’s H1N1 vaccine, Pandemrix, which includes the adjuvant AS03. AS03 contains an artificial vitamin E, DL-α-tocopherol, polysorbate 80, and  squalene. Other vaccine ingredients include formaldehyde, sodium deoxycholate, and sucrose.

The authors found a high rate of “FDG-avid lymph nodes after immunologic H1N1 influenza virus vaccination”. That is, the lymph nodes of people who’d recently had F1N1 vaccinations were significantly affected by the vaccine. Their conclusion is:

We suggest that this finding in combination with increased activity at the ipsilateral intramuscular injection site is a strong indication of vaccination-related, reactive lymphadenopathy.

That means they believe the results show that the vaccine is causing diseased lymph nodes. Apparently, the vaccine’s adjuvants put the lymph system under excessive stress by having to detox the adjuvants.

Vaccines Fueling Non-Hodgekin’s Lymphoma?

The question, of course, is whether vaccination’s extra stress on the lymph system is fueling the hugely increased incidence of non-Hodgekin’s lymphoma. Of course, at this time there is no definitive answer. However, let’s consider the rate of increase in this kind of cancer from 1975-2007. The Townsend Letter, in an article titled “The US Cancer Program and Specific Types of Cancer, 1975–2007: A Failure – Part 2“, the authors analyzed the incidence and mortality rates of US cancer between 1975 and 2007.

The researchers found that non-Hodgekin’s lymphoma had increased by 91% during that time. Vaccinations also increased during that same period—and the increase had started a couple of decades earlier, just enough time to see cancer rates increase. Meanwhile, during the span of years from 1975 through 2007, the rate of vaccinations continued to increase.

With this new study, we’re seeing a positive connection between stress on lymph nodes and cancer of them. We’re also seeing a potential causative link, because we already know that excessive stress on other organs of detoxification, such as the liver and kidneys, tends to cause cancer to develop.

Therefore, it’s only reasonable to assume that a connection exists between vaccines and non-Hodgekin’s lymphoma. We can further guess that this kind of cancer will continue to increase over the next decades, because we continue to add to the vaccination load, and particularly, to the adjuvant load within the vaccines.

Vaccinations are a huge profit center for Big Pharma, and most studies are carried out either by them or through their pet agencies. Results contrary to the pharmaceutical industry’s wishes are suppressed. As a result, honest research is rare. That’s why it’s only through accidental findings, like those in the study reported on here, that the truth may be ascertained.

How Seriously Should We Take This?

One might ask if we should take such a connection seriously, in light of the fact that it wasn’t the focus of the study. However, we need to look at the overall picture. If harm is being done, but the fact of it is suppressed—as we’ve seen over and over in Big Pharma research—errors need to be made on the side of caution.

At this point, we know that vaccinations do, indeed, cause significant harm, in spite of the suppression of that information. We know also that they can fuel the diseases that they purport to resolve, as in the case of virulent new whooping cough.

Considering the nature of the danger involved—life threatening non-Hodgkin’s lymphoma cancer—it is only reasonable to assume that vaccinations are now fueling the massive increase in that cancer. Because we also know that site-related carcinomas in cats and dogs are caused by vaccines, we have every reason to expect that there may be other cancers associated with or caused by vaccinations.

It’s long past time to put vaccinations through the same sort of placebo-controlled, randomized, double blind studies that Big Pharma and its apologists have consistently refused to do on vaccines, while insisting that it’s the gold standard. It is further necessary to carry out longitudinal studies, so that we can ascertain the long term adverse effects. The risks are clearly far too high, and the evidence of both lack of efficacy and significant harm keeps mounting, in spite of extreme efforts to keep that information hidden.

Tagged big pharma, conventional medicine, h1n1 vaccine, lymph disease, modern medicine, non-hodgkin's lymphoma, non-Hodgkins lymphoma adjuvant, non-Hodgkins lymphoma vaccines, pharmaceutical drugs, pharmaceuticals, swine flu vaccine, vaccine adjuvant, vaccines